Maryland Cannabis Sales Top $20M During First Week

Jul 12, 2023 | Cannabis

Maryland Cannabis Sales Top $20M During First Week During the first week of sales after the July 1 launch of Maryland’s adult-use cannabis market, dispensaries in the state sold nearly $21 million worth of product. Combined medical and adult-use cannabis sales in...

BERKELEY OFFICIALLY DECRIMINALIZES POSSESSION OF PSILOCYBIN MUSHROOMS AND AYAHUASCA

Jul 12, 2023 | Psychedelics

BERKELEY OFFICIALLY DECRIMINALIZES POSSESSION OF PSILOCYBIN MUSHROOMS AND AYAHUASCA In an unanimous move, Berkeley has officially deprioritized arrests for possession and use of psilocybin and ayahuasca. Berkeley has long been an epicenter of psychedelic research and...

UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey

Jul 12, 2023 | Psychedelics

UC Berkeley Center for the Science of Psychedelics Unveils Results of the First-Ever Berkeley Psychedelics Survey More than six in ten (61%) American registered voters support legalizing regulated therapeutic access to psychedelics, including 35% who report “strong”...

Another California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill

Jul 11, 2023 | Psychedelics

Another California Assembly Committee Approves Senate-Passed Psychedelics Legalization Bill A second California Assembly committee has approved a Senate-passed bill to legalize the possession and facilitated use of certain psychedelics, bringing it one step closer to...

Psychedelic helpline shows promise in helping to manage safety issues and emotional challenges

Jul 11, 2023 | Psychedelics

Psychedelic helpline shows promise in helping to manage safety issues and emotional challenges The presence of a psychedelic helpline appears to be beneficial in averting harmful outcomes and alleviating the burden on emergency services, according to new research...

PSILOCYBIN MAY BE MORE COST-EFFECTIVE THAN CURRENT TREATMENTS FOR DEPRESSION, MAJOR NEW STUDY FINDS

Jul 6, 2023 | Psychedelics

PSILOCYBIN MAY BE MORE COST-EFFECTIVE THAN CURRENT TREATMENTS FOR DEPRESSION, MAJOR NEW STUDY FINDS A major new study has found that psilocybin-based treatment combined with therapy may provide more cost-effective solution to treating depression than methods such as...